Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Koninklijke Ahold | Milan | Consumer Non-Cyclicals | Food & Drug Retailing | €28.93B | 15.8x | -0.74 | €30.83 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marr | Milan | Consumer Non-Cyclicals | Food & Drug Retailing | €782.27M | 17x | 0.46 | €12.06 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.1% Upside | Upgrade to Pro+ | |
IVS Group SA | Milan | Consumer Non-Cyclicals | Food & Drug Retailing | €645.81M | 38.2x | 0.36 | €7.14 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.1% Upside | Upgrade to Pro+ | |
Orsero | Milan | Consumer Non-Cyclicals | Food & Drug Retailing | €214.31M | 7.2x | -0.21 | €12.72 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Longino & Cardenal | Milan | Consumer Non-Cyclicals | Food & Drug Retailing | €15.25M | -29x | -0.52 | €2.44 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Compagnia dei Caraibi SpA | Milan | Consumer Non-Cyclicals | Food & Drug Retailing | €13.31M | -0.9x | 0 | €0.93 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29% Upside | Upgrade to Pro+ |